Piper Sandler Companies reported robust financial results for Q4 2024, significantly surpassing analyst expectations. The company achieved earnings per share (EPS) of $4.80, exceeding the forecasted ...
Q4 2024 Earnings Call Transcript January 31, 2025 Piper Sandler Companies beats earnings expectations. Reported EPS is $4.8, ...
Q4 2024 Earnings Conference Call January 31, 2025 9:00 AM ETCompany ParticipantsKate Winslow - IRChad Abraham - ...
Piper Sandler downgrades Hershey Co. to underweight from neutral on expectation of stubbornly high cocoa prices.
Piper Sandler Companies (PIPR) delivered earnings and revenue surprises of 32.60% and 14.57%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the ...
The company declared a special cash dividend of $3.00 per share of common stock and a quarterly cash dividend of 65c per share of common stock ...
Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Praxis Precision Medicines (PRAX – Research Report) today and set a price ...
Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, today announced the pricing of its upsized initial ...
F5 Inc (NASDAQ:FFIV) stock is trading higher Wednesday after the company reported better-than-expected first-quarter ...
As attention on Chinese startup DeepSeek and its artificial-intelligence model led to a $1 trillion wipeout in the U.S. stock market on Monday, shares of bitcoin miners with exposure to artificial ...
In a note to investors on Jan. 22, investment bank Roth Capital downgraded the stock to Neutral from Buy. The investment bank ...